首頁
MannKind Corporation

11月 2025MannKind Corporation的市場佔有率分析

MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991.

健康 > 生物技術和製藥

域名mannkindcorp.com

成立年份1991

僱員201 - 500

年度營收$50M - $75M

MannKind Corporation

MannKind Corporation（包含公司地區）

mannkindcorp.com

查看更多網站流量與參與度資訊

MannKind Corporation截至 11月 2025 的總收入為 50M - 75M

MannKind Corporation 熱門網域產生的總收入

MannKind Corporation 熱門網域 3 年內的總收入

MannKind Corporation 熱門網域的總收入

mannkindcorp.com50M - 75M

透過銷售情報查看更多內容

MannKind Corporation的熱門網域總造訪量

了解MannKind Corporation市場觸達率與潛在市場影響力。

過去 3 個月的訪問總量

子公司細目

mannkindcorp.com14.4K

透過銷售情報查看更多內容

MannKind Corporation的熱門網域平均造訪時長

分析MannKind Corporation參與度指標。

過去 3 個月平均造訪時長

子公司細目

mannkindcorp.com00:00:07

透過銷售情報查看更多內容

MannKind Corporation的熱門網域平均頁面瀏覽量

了解MannKind Corporation如何保持使用者的參與度、培養其興趣，並鼓勵他們採取下一步。

過去 3 個月平均頁面瀏覽量

子公司細目

mannkindcorp.com1.25

透過銷售情報查看更多內容

MannKind Corporation按網域劃分的熱門競爭對手

11月 2025的熱門類似網站，依相似度排名

merck.com公司名Merck僱員> 10001總部美國, 新澤西州, Kenilworth年度營收> $1B訪問總量1.4M健康 > 生物技術和製藥

使用的熱門技術MannKind Corporation

这些是MannKind Corporation顶级域名使用的行业网站技术

付款與貨幣 (8)

Cart Functionality

小工具 (5)

Twemoji

付費廣告 (4)

DoubleClick

市場行銷 (4)

Google Marketing Platform

更多技術

12

檢視所有

新聞與訊號來自MannKind Corporation

透過 Similarweb 銷售訊號提醒，每當目標受眾出現新的機會或威脅時，你就會收到每日更新的已識別購買訊號。

新聞MannKind Corp. attends event Jefferies global Healthcare Conference.DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Nov. 11, 2025 (GLOBE NEWSWIRE) - MannKind Corporation (Nasdaq: MNKD) announced today that Michael Castagna, Chief Executive Officer, and Chris Prentiss, Chief Financial Officer, are scheduled to present and share updates during the Jefferies London Healthcare Conference on Wednesday, November 19, at 6:30 am ET/11:30 am GMT.

新聞MannKind Corp. hired Ajay Ahuja as Executive Vice President and Chief Medical Officer on Sep 29th '25.WESTLAKE VILLAGE, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) - MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of innovative inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, today announced the appointment of Ajay Ahuja, MD, MBA, as Chief Medical Officer, effective today.

新聞MannKind Corp. is developing second dry powder inhalation therapy.MannKind Corporation collaborates with United Therapeutics to develop second dry powder inhalation therapy.